BXP (BXP) Secures 343 Madison Financing, Is The Stock Already Fully Valued?

Why BXP stock is in focus after the 343 Madison Avenue financing

BXP (BXP) has drawn fresh attention after closing a $1.2b construction loan for its planned 46 story 343 Madison Avenue tower in Midtown Manhattan. This marks a key step in funding this US$2b project.

See our latest analysis for BXP.

The financing news comes as BXP shares trade at US$72.97, with recent momentum reflected in a 4.30% 1 day share price return and a 24.82% 90 day share price return. The 1 year total shareholder return sits at 14.74%, while the 5 year total shareholder return shows a decline of 17.47%, suggesting improving recent sentiment after a weaker longer term stretch.

If you are looking beyond BXP for other ideas in real assets and infrastructure, this could be a useful moment to review 34 power grid technology and infrastructure stocks

The recent jump in BXP after the 343 Madison Avenue financing has narrowed the gap to external price targets, yet a material intrinsic discount is still flagged. How much of the opportunity might still sit in the valuation work rather than the past move?

Most Popular Narrative: 5.7% Overvalued

On the most followed narrative, BXP screens on a fair value of $69.05 compared with the latest close at $72.97, so the story leans slightly rich on that framework.

BXP's aggressive capital recycling and asset sales strategy (targeting $600 million in non-core dispositions), along with redevelopment and adaptive reuse of assets for mixed-use and multifamily, is expected to unlock higher-yielding income streams, fortify net margins, and provide non-dilutive funding for growth, supporting future FFO and earnings resilience.

Read the complete narrative.

Want to see what assumptions sit behind that price tag for BXP? The whole narrative leans on steady revenue expansion, firm margins and a richer future earnings multiple.

Result: Fair Value of $69.05 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, BXP still faces risks around leasing softness in some key markets and the sizeable funding and execution burden tied to the US$2b 343 Madison project.

Find out about the key risks to this BXP narrative.

Another View on BXP’s Valuation

The popular narrative has BXP screening modestly overvalued on a fair value of $69.05 against a $72.97 share price. The SWS DCF model points a different way. It estimates future cash flow value at $88.43, which is about 17.5% above today’s price and screens as undervalued.

These are two methods, two signals, with a wide spread between them. The question for you is which set of assumptions feels closer to how BXP’s cash flows and risks might play out.

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out BXP for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 49 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With mixed signals on BXP's valuation and outlook, this is a good time to move quickly. Review the details and weigh both sides through the 3 key rewards and 4 important warning signs

Looking for more investment ideas beyond BXP?

Do not stop with BXP. Use this momentum to scan wider opportunities so you are not relying on a single story when markets shift again.

• Target potential mispricings by checking out companies that appear to offer quality at a discount through the 49 high quality undervalued stocks.
• Strengthen your search for income by reviewing companies that feature consistent payouts through the 9 dividend fortresses.
• Protect against big setbacks by focusing on companies that register lower risk profiles via the 85 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com